ALGS vs APH · rev $3.6M vs P/E 40, rev $23.09B
Aligos Therapeutics Inc (ALGS) versus Amphenol Corporation (APH) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Amphenol Corporation (APH) is a electronic components company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
ALGS currently screens at market cap $44.1M. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Not investment advice. Open the ALGS and APH stock pages for the full models.
Not investment advice.